Paying the piper for pharmacoeconomic studies. - Wikidata - awgldk - TriplyDB

Paying the piper for pharmacoeconomic studies.

Paying the piper for pharmacoeconomic studies.

http://www.wikidata.org/entity/Q53579137

about

When are statins cost-effective in cardiovascular prevention? A systematic review of sponsorship bias and conclusions in economic evaluations of statins.Health economists meet the fourth tempter: drug dependency and scientific discourse.

P2860

Q34828582-83558020-51E8-4E91-92C6-8A3DD6AA1C36 Q52927347-F112F96B-349B-463D-8BD6-013697C07B0B

P2860

Paying the piper for pharmacoeconomic studies.

http://www.wikidata.org/entity/Q53579137

description

1998 nî lūn-bûn

@nan

1998年の論文

@ja

1998年学术文章

@wuu

1998年学术文章

@zh

1998年学术文章

@zh-cn

1998年学术文章

@zh-hans

1998年学术文章

@zh-my

1998年学术文章

@zh-sg

1998年學術文章

@yue

1998年學術文章

@zh-hant

name

Paying the piper for pharmacoeconomic studies.

@en

Paying the piper for pharmacoeconomic studies.

@nl

type

label

Paying the piper for pharmacoeconomic studies.

@en

Paying the piper for pharmacoeconomic studies.

@nl

prefLabel

Paying the piper for pharmacoeconomic studies.

@en

Paying the piper for pharmacoeconomic studies.

@nl

P1433

Q53579137-FE25493B-4714-47C8-A601-8DB0A31A1541

P1476

Q53579137-E4E527A0-F364-4B70-90DF-429E658FF399

P2093

Q53579137-D9F04D7D-8718-4C44-B304-4B4EFCA515DB

P2860

Q53579137-089CD240-798B-4A22-A57B-10139076A2BD

Q53579137-37A967A1-2CEA-4504-87E7-CCBCAC499EAA

Q53579137-5F7EFD16-2053-4A51-B0F4-FEC97A278F26

Q53579137-6576669A-6CCF-4CB6-BE9F-6996EF24F642

Q53579137-65969024-0ACE-44E2-A0EB-BA9FC80A7F3D

Q53579137-82AB5748-9CAF-4F05-8BA6-569CF10714DC

Q53579137-A678C898-5826-4A06-9B83-E85D2ADA4C09

Q53579137-B45DE6D9-7C52-4A28-8461-FF98D27AD9AF

Q53579137-BAEE1793-B2FA-4109-AF58-B93AF07BA03E

Q53579137-D6C55C46-ADE6-40A0-89A2-FB3A5D39FA0A

P304

Q53579137-27CF41B9-D2ED-44D8-A13D-56248D87F105

P31

Q53579137-2AD72C01-BE0C-4E18-ACAE-41957B2BD073

P356

Q53579137-D5BAABF1-FCD6-4DE3-90E1-265A700EF0E3

P433

Q53579137-5F759DE2-FA14-450D-B3ED-E6035FC93ADF

P478

Q53579137-21F5F196-E1BA-41E0-AF37-B0DE0FC01804

P577

Q53579137-D76D7618-C0F1-4D86-A82E-42F0E196F03D

P698

Q53579137-E1C483FA-EB6E-49A8-8813-A09C3F06F1F0

P356

0272989X98018002S05

P1433

Medical Decision Making

P1476

Paying the piper for pharmacoeconomic studies.

@en

P2093

P J Neumann

http://www.w3.org/2001/XMLSchema#string

P2860

Why training is the key to successful guideline implementation.

Cost-effectiveness and cost-benefit analyses in the medical literature. Are the methods being used correctly?

Guidelines for authors and peer reviewers of economic submissions to the BMJ. The BMJ Economic Evaluation Working Party.

Awareness of providers' use of new medical technology among private health care plans in the United States.

Making economic evaluations respectable.

Ethics, economics, and the publication policies of major medical journals.

Are methods for estimating QALYs in cost-effectiveness analyses improving?

Are guidelines for peer-reviewing economic evaluations necessary? A survey of current editorial practice.

Recommendations of the Panel on Cost-effectiveness in Health and Medicine.

Foundations of cost-effectiveness analysis for health and medical practices.

P304

S23-6

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1177/0272989X98018002S05

http://www.w3.org/2001/XMLSchema#string

P433

2 Suppl

http://www.w3.org/2001/XMLSchema#string

P478

18

http://www.w3.org/2001/XMLSchema#string

P577

1998-04-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

9566464

http://www.w3.org/2001/XMLSchema#string